RHYTHM (Formerly Escape II Myocardium)

PHASE4CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

October 10, 2011

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Rheumatoid Arthritis
Interventions
DRUG

TNF inhibitors

"TNF inhibitors are an FDA approved class of medications indicated for the treatment of RA when initial treatment (usually with methotrexate) has failed to achieve remission of RA disease activity. TNF inhibitors are part of the standard of care management of RA.~The possible TNF inhibitors are: Remicade, Humira, Enbrel, Cimzia, Simponi."

DRUG

DMARDs

Standard of care treatment for RA, such as Methotrexate or other disease-modifying antirheumatic drugs.

Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Columbia University

OTHER

NCT01548768 - RHYTHM (Formerly Escape II Myocardium) | Biotech Hunter | Biotech Hunter